CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$4.56
+9.62%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$4.12
From 52W high−85.48%
Volume156018.00
Market cap$8.62M
P/E (TTM)—
P/S (TTM)22.2x
Div yield—
Key dataSep 18, 2026
Open
$4.12
From 52W high
−85.48%
Volume
156018.00
Market cap
$8.62M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
P/E (TTM)
—
RSI (14)
70.6
MomentumView details →
1D Return
+9.62%
YTD Return
−67.71%
SummaryUpdated Mar 1, 2026
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) is an Israeli biotechnology company founded in 2004 and headquartered in Rehovot, Israel. The company went public on NASDAQ in January 2018. CollPlant specializes in regenerative and aesthetic medicine, focusing on developing innovative medical products based on recombinant human collagen produced through proprietary plant-based genetic engineering technology. The company operates in the rapidly evolving biotechnology sector, developing solutions for tissue regeneration, wound care, and aesthetic medicine applications.
Similar companies
Latest newsMore news →
CollPlant Biotechnologies will host an investor webinar on September 17, 2026 to present LightSolver.10d agoCollPlant is acquiring LightSolver, entering the supercomputing and photonic computing markets.20d agoCollPlant Biotechnologies entered into a definitive agreement for a private placement of ordinary shares and warrants to raise $2.6 million.82d ago